Possible Founder Effect of Glycine Encephalopathy: Evidence of a GLDC c. 2714T >G (p. Val905Gly ) Common Variant in the Paisa Community Based in Cali, Colombia
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64173 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Stiven Ernesto Sinisterra-Diaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia. Hauptthemen laut MEDLINE: Founder Effect, Hyperglycinemia, Nonketotic, Glycine Dehydrogenase (Decarboxylating). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Non‐ketotic hyperglycinemia (NKH) is a rare autosomal recessive disorder caused by defects in the mitochondrial glycine cleavage system, most commonly involving variants in GLDC . Clinical presentation is heterogeneous, ranging from severe neonatal encephalopathy with intractable epilepsy to attenuated forms with variable neurodevelopmental outcomes. We conducted a comprehensive clinical, biochemical, molecular, and genealogical analysis of eight Colombian patients with NKH, all of whom shared ancestry from the Paisa population. All patients were born at term after uncomplicated pregnancies and presented in the neonatal period with hypotonia, lethargy, feeding difficulties, and treatment‐resistant seizures. Elevated glycine levels were detected in plasma for all patients and cerebrospinal fluid in three cases. Molecular testing identified the same homozygous GLDC variant (NM_000170.3:c.2714 T>G; p.Val905Gly) in all individuals. Although no consanguinity was reported, shared surname and regional ancestry suggested intra‐ and interfamilial isonymy, raising the possibility of a founder effect. Clinical outcomes varied despite the implementation of early supportive interventions. This is the first report of a recurrent GLDC variant in Colombian patients, supporting a potential founder effect in the Paisa population. These findings highlight the importance of regional genetic studies in enhancing diagnostic precision and guiding population‐specific strategies for rare disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia.
- Genetics Service, Fundación Valle del Lili, Cali, Colombia.
- Division of Genetics, Genomics, and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, USA.
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, USA.
- Facultad de Ciencias de la Salud, Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Icesi, Cali, Colombia.
ORCID-Profile: Stiven Ernesto Sinisterra-Diaz, Harry Pachajoa
Zitieren
APA
Sinisterra-Diaz, S. E., Prada, C. E., & Pachajoa, H. (2025). Possible Founder Effect of Glycine Encephalopathy: Evidence of a GLDC c. 2714T >G (p. Val905Gly ) Common Variant in the Paisa Community Based in Cali, Colombia. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64173
Vancouver
Sinisterra-Diaz SE, Prada CE, Pachajoa H. Possible Founder Effect of Glycine Encephalopathy: Evidence of a GLDC c. 2714T >G (p. Val905Gly ) Common Variant in the Paisa Community Based in Cali, Colombia. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64173
BibTeX
@article{SinisterraDiaz2025,
author = {Sinisterra-Diaz, Stiven Ernesto and Prada, Carlos E and Pachajoa, Harry},
title = {Possible Founder Effect of Glycine Encephalopathy: Evidence of a GLDC c. 2714T >G (p. Val905Gly ) Common Variant in the Paisa Community Based in Cali, Colombia},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64173}
}
EUVIMED